Javascript must be enabled to continue!
Ets1 suppresses atopic dermatitis by suppressing pathogenic T cell responses
View through CrossRef
Atopic dermatitis (AD) is a complex inflammatory skin disease mediated by immune cells of both adaptive and innate types. Among them, CD4
+
Th cells are one of major players of AD pathogenesis. Although the pathogenic role of Th2 cells has been well characterized, Th17/Th22 cells are also implicated in the pathogenesis of AD. However, the molecular mechanisms underlying pathogenic immune responses in AD remain unclear. We sought to investigate how the defect in the AD susceptibility gene,
Ets1
, is involved in AD pathogenesis in human and mice and its clinical relevance in disease severity by identifying Ets1 target genes and binding partners. Consistent with the decrease in ETS1 levels in severe AD patients and the experimental AD-like skin inflammation model, T cell–specific Ets1-deficient mice (Ets1
ΔdLck
) developed severe AD-like symptoms with increased pathogenic Th cell responses. A T cell–intrinsic increase of gp130 expression upon Ets1 deficiency promotes the gp130-mediated IL-6 signaling pathway, thereby leading to the development of severe AD-like symptoms. Functional blocking of gp130 by selective inhibitor SC144 ameliorated the disease pathogenesis by reducing pathogenic Th cell responses. Our results reveal a protective role of Ets1 in restricting pathogenic Th cell responses and suggest a potential therapeutic target for AD treatment.
American Society for Clinical Investigation
Title: Ets1 suppresses atopic dermatitis by suppressing pathogenic T cell responses
Description:
Atopic dermatitis (AD) is a complex inflammatory skin disease mediated by immune cells of both adaptive and innate types.
Among them, CD4
+
Th cells are one of major players of AD pathogenesis.
Although the pathogenic role of Th2 cells has been well characterized, Th17/Th22 cells are also implicated in the pathogenesis of AD.
However, the molecular mechanisms underlying pathogenic immune responses in AD remain unclear.
We sought to investigate how the defect in the AD susceptibility gene,
Ets1
, is involved in AD pathogenesis in human and mice and its clinical relevance in disease severity by identifying Ets1 target genes and binding partners.
Consistent with the decrease in ETS1 levels in severe AD patients and the experimental AD-like skin inflammation model, T cell–specific Ets1-deficient mice (Ets1
ΔdLck
) developed severe AD-like symptoms with increased pathogenic Th cell responses.
A T cell–intrinsic increase of gp130 expression upon Ets1 deficiency promotes the gp130-mediated IL-6 signaling pathway, thereby leading to the development of severe AD-like symptoms.
Functional blocking of gp130 by selective inhibitor SC144 ameliorated the disease pathogenesis by reducing pathogenic Th cell responses.
Our results reveal a protective role of Ets1 in restricting pathogenic Th cell responses and suggest a potential therapeutic target for AD treatment.
Related Results
Abstract 1707: Androgen responsiveness of the NKX3.1 gene is regulated by the proto-oncogene ETS1
Abstract 1707: Androgen responsiveness of the NKX3.1 gene is regulated by the proto-oncogene ETS1
Abstract
Expression of the prostatic homeodomain protein NKX3.1 is androgen-regulated in both the normal prostate and in prostate cancer cells. Androgen responsivene...
EVALUATION OF FOOD SENSITIVITY IN CHILDREN WITH ATOPIC DERMATITIS
EVALUATION OF FOOD SENSITIVITY IN CHILDREN WITH ATOPIC DERMATITIS
Objective: Atopic dermatitis is considered an important risk factor for the development of food allergies. This retrospective study aimed to evaluate food sensitivity in pediatric ...
The Course of Life of Patients with Childhood Atopic Dermatitis
The Course of Life of Patients with Childhood Atopic Dermatitis
Abstract: Atopic dermatitis mainly covers the period of infancy to adulthood, an important period in the development of an individual. The impairment of quality of life and the ps...
Association between Resistin Gene Polymorphisms and Atopic Dermatitis
Association between Resistin Gene Polymorphisms and Atopic Dermatitis
Atopic dermatitis (AD) is a chronic, relapsing, and inflammatory skin disorder. It is characterized by an inappropriate skin barrier function, allergen sensitization, and recurrent...
Karakteristik Klinis dan Status Gizi Pasien Dermatitis Anak Puskesmas Kalijati 2024-2025
Karakteristik Klinis dan Status Gizi Pasien Dermatitis Anak Puskesmas Kalijati 2024-2025
Abstract. Dermatitis is a common inflammatory skin disease in children. This study aimed to describe the clinical characteristics and nutritional status of pediatric dermatitis pat...
Expression of 27 KD, 65 KD and 72/73 KD Heat Shock Protein in Atopic Dermatitis: Comparison with Those in Normal Skin and Contact Dermatitis
Expression of 27 KD, 65 KD and 72/73 KD Heat Shock Protein in Atopic Dermatitis: Comparison with Those in Normal Skin and Contact Dermatitis
AbstractThe expression of Heat Shock Protein (HPS) 72/73, HSP65 and HSP27 in skin lesions of atopic dermatitis (n=21) was studied and compared with that in contact dermatitis (n=18...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis
Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis
Background: Atopic dermatitis is a common chronic inflammatory skin condition. It affects upto 20% of children and 3% of atopic dermatitisults; most of them are mild to moderate in...

